In a study of 14 patients (11 Japanese and 3 white North Americans) with aldosterone-producing tumor carried out within 2 to 4 weeks after unilateral adrenalectomy, both plasma renin activity (PRA) and plasma aldosterone concentration (PAC) increased almost normally with shortterm sodium depletion and upright posture. Aldosterone excretion rate (AER) also increased significantly with sodium depletion, and was normally suppressed by sodium loading. Highly significant correlations were observed between PRA and PAC (r=0.89, p<0.001) or AER (r= 0.88, p<0.001) ater operation, whereas there had been no such correlation before operation. Either physiological or laboratory findings were normalized or markedly improved in all cases although pathohistological diagnosis was made as adenomatous hyperplasia in 10 out of 11. These results indicate that within 4 weeks of operation PRA and the remaining adrenal gland can almost normally respond to stimuli such as sodium depletion and upright posture regardless of the amount of spironolactone given preoperatively. Additional Indexing Words: Plasma renin activity Plasma aldosterone concentration Aldosterone excretion rate Spironolactone Adenoma Adenomatous hyperplasia MMEDIATE falls of aldosterone production were observed after removal of aldosterone-producing tumors in primary aldosteronism.1),2) Biglieri and his co-workers3) reported that chronic hypervolemia and hypertension in primary aldosteronism could result in selective suppression of aldosterone
production immediately after removal of aldosterone-producing tumor. The juxtaglomerular apparatus is thought to be suppressed as a result of the longstanding hypervolemia and hypertension that occur secondary to elevated aldosterone production.4)-6) However, Bravo and his co-workers7) have reported that the low plasma renin is not the principal cause of postoperative selective hypoaldosteronism, because patients treated with enough spironolactone preoperatively to raise PRA above normal produced inappropriately too little aldosterone for the corresponding plasma renin in the immediate postoperative period.
In our experience, however, no replacement therapy with steroid hormones was necessary after removal of aldosterone-producing tumor. Besides, in most of our cases neither contralateral nor ipsilateral adrenocortical tissue other than the adenoma or adenomatous hyperplasia showed atrophic, but rather proliferative and/or micronodular hyperplastic changes.1),2), 8) The present study was made to assess whether the remaining adrenocortical tissue shortly after removal of unilateral adrenal gland bearing aldosteroneproducing tumor would be able to respond normally to various stimuli such as several manipulations of dietary sodium and postural change.
MATERIALS AND METHODS
Patients: Fourteen patients with primary aldosteronism were the subjects of this study. Eleven of them (3 males and 8 females) were Japanese, ranging in age from 20 to 58 years (average 37.6 years) and 3 of them (2 males and 1 female) were white North American patients of mixed ethnic background, ranging in age from 36 to 54 years. The Japanese patients were hospitalized at Kyushu University Hospital (KUH) in Fukuoka, the white patients at the Clinical Center of the National Institutes of Health (NIH), Bethesda, Maryland. Diagnosis was based on hypertension, hypokalemia, increased plasma aldosterone concentration (PAC), and/or urinary aldosterone excretion rate(AER), suppressed plasma renin activity (PRA) and normal urinary excretion of 17-hydroxycorticosteroids (17-OHCS) and 17-ketosteroids (17-KS). A unilateral abnormality was identified on the adrenal scintiphoto scan after the administration of 131I-19-iodocholesterol, adrenal venography and measurement of bilateral adrenal vein plasma concentration of aldosterone. All had normal renal, hepatic, and cardiac function. They were found, on operation, to have aldosterone-producing tumors. All patients received spironolactone preoperatively.
Protocol: The patients were studied preoperatively under 3 different dietary conditions as follows:
1) Phase I (Control Diet): Daily dietary sodium of 194mEq was given for at least 5 days at KUH and of 109mEq for 7 days at NIH.
2) Phase II (Low-salt Diet): The patients at KUH were given a salt-poor diet (34mEq of sodium per day) for 4 to 5 days. They were given 120mg of furosemide orally in the morning on the first day of this span to initiate negative (Table II) Blood pressure and serum Na fell significantly (p<0.001) and serum K rose significantly (p<0.001), whereas urinary excretion of Na and K, 17-OHCS and 17-KS did not change after operation.
Spironolactone administration (Table III) Spironolactone was given to all patients in Japan at dosages ranging from 50 to 400mg/day, for periods ranging from 11 to 226 days, before operation. The total dose given averaged 7,300mg, and 4 out of 11 patients received more than 10,000mg. Spironolactone was not given to any patients after operation. Pre-and postoperative study of the renin-angiotensin-aldosterone system in 3 white patients with primary aldosteronism in the United States Data are shown in Table IV . Complete studies were performed on 2 out of 3 patients, whose responses to dietary sodium manipulation following operation were quite similar to those of the Japanese patients; They were given 200 and 400mg/day of spironolactone for 6 and 5 months (total: 36,000 and 63,000mg) before a unilateral adrenalectomy was done. The remaining 1 also received a large amount of spironolactone for more than 6 months. An entire metabolic balance study at the Clinical Center of NIH is illustrated in Fig. 4 .
Histopathological findings Table V lists the histopathological findings at operation. In no case did the ipsilateral adrenal tissue surrounding the tumor show "atrophy" on microscopic examination. of a tumor2) showed essential differences between the cases with adenoma and adenomatous hyperplasia. Therefore, our patients are not different from those with aldosterone-producing adenoma described by others.3),7),16) It was reported that restoration of aldosterone production did not observe for at least 1 month after removal of aldosterone-producing tumor.3),7),16) Biglieri and his coworkers3) suggested that long-term suppression of renin secretion by hypervolemia and hypertension was thought to account for the subnormal production of aldosterone by the remaining adrenal gland. In most of our cases, however, both PRA and aldosterone responded normally to sodium depletion and to the upright posture within 2 to 4 weeks after operation. Again, hormonal replacement therapy such as fludrocortisone or corticosterone administration was not required not only in our patients investigated here or previously reported1),3),8) but also in many others .17)-20) The histopathological findings in our patients did not suggest depression of aldosterone secreting capacity, since there was no suggestion of atrophy either on the same side as the tumor, or contralaterally.1),2),8) Similar histological findings were observed by others.17)-22) Tsuchiyama23) has emphasized the contribution of zona glomerulosa of nontumorous area to the excess of aldosterone production in patients with primary aldosteronism in terms of morphological and histochemical standpoints. Contralateral adrenal gland seems to be able to respond well to various stimuli to increase aldosterone production.
Morimoto and his co-workers16) found that large doses of spironolactone (300 to 400mg/day) for 2 months or more before operation prevented the nonresponsiveness of PRA to appropriate stimuli following removal of aldosterone-producing tumor, whereas low levels of AER were observed within at least 1 month after operation. After preoperative treatment with small or moderate doses of spironolactone for periods as short as 11 days or as long as 1 year, all our patients could respond almost normally to sodium depletion and to the upright posture with increases in PRA, PAC, and AER within 2 to 4 weeks after operation although only 4 patients received more than 10,000 mg of spironolactone as shown in Table III . Three cases in NIH also revealed almost normal values in PRA and aldosterone postoperatively and responded well to the sodium depletion or to the upright posture despite taking a large amount of spironolactone preoperatively. These results are inconsistent with those of other investigators.7), 16) Bravo and his co-workers7) showed that postoperative unresponsiveness of aldosterone secretion occurred even after prolonged use of spironolactone preoperatively at dosages sufficient to raise PRA to supernormal values for prolonged intervals. They considered that such suppression could account for the failure of their patients to produce aldosterone postoperatively despite supernormal values for PRA and suggested that spironolactone itself inhibited the adrenal cortex since there had been considerable experimental evidences that spironolactone could suppress the biosynthesis of aldosterone.24)-27) In the present study, however, highly significant correlation between PRA and PAC or AER was observed within 1 month following removal of aldosterone-producing tumor. Even if inhibiting aldosterone biosynthesis occurred in our patients, it must have been short-lived.28)
These evidences support our conclusion that the juxtaglomerular apparatus and the contralateral adrenal gland might respond almost normally to the upright posture or sodium deprivation within 1 month following removal of an aldosterone producing tumor regardless of the amount of spironolactone given preoperatively.
